Ayala Pharmaceuticals, Inc. Quarterly Earnings Per Share, Diluted in USD/shares from Q2 2010 to Q3 2023

Taxonomy & unit
us-gaap: USD/shares
Description
The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.
Summary
Ayala Pharmaceuticals, Inc. annual/quarterly Earnings Per Share, Diluted history and growth rate from Q2 2010 to Q3 2023.
  • Ayala Pharmaceuticals, Inc. Earnings Per Share, Diluted for the quarter ending September 30, 2023 was -1.53 USD/shares, a 56.4% increase year-over-year.
  • Ayala Pharmaceuticals, Inc. annual Earnings Per Share, Diluted for 2023 was -7.99 USD/shares, a 39.1% increase from 2022.
  • Ayala Pharmaceuticals, Inc. annual Earnings Per Share, Diluted for 2022 was -13.1 USD/shares.
  • Ayala Pharmaceuticals, Inc. annual Earnings Per Share, Diluted for 2011 was -0.04 USD/shares, a 42.9% increase from 2010.
Earnings Per Share, Diluted, Quarterly (USD/shares)
Earnings Per Share, Diluted, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2023 -$2 +$1.98 +56.4% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-20
Q2 2023 -$2 +$1.01 +35.7% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-10
Q3 2022 -$4 Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-20
Q2 2022 -$3 Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2020 $0 +$1.49 +93.7% Feb 1, 2020 Apr 30, 2020 10-Q 2020-06-11
Q1 2019 -$2 +$2.44 +60.5% Feb 1, 2019 Apr 30, 2019 10-Q 2020-06-11
Q1 2018 -$4 Feb 1, 2018 Apr 30, 2018 10-Q 2019-06-10
Q2 2012 $0 $0 -200% May 1, 2012 Jul 31, 2012 10-Q/A 2012-10-04
Q2 2011 $0.01 $0 0% May 1, 2011 Jul 31, 2011 10-Q/A 2012-10-04
Q2 2010 $0.01 May 1, 2010 Jul 31, 2010 10-Q 2011-09-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.